You have submitted an FOI request
Date: Oct. 5, 2024, 10:55 p.m.
Your request is already in review
Your request was denied
Date: 2024-10-12 17:06:52.704005
How was your request?
Published by Dangerous Drugs Board(DDB) on Oct. 5, 2024.
Requested from DDB by E. Sanidad at 10:55 PM on
Oct. 5, 2024.
Purpose: Undergraduate Thesis
Tracking no: #DDB-271358123610
Hi! I would like to request the following information: 1) Statistics on what are the current opioid prescribed drugs commonly used in the PH 2) Demographics of those who use it and/or who are commonly prescribed with it 3) Current sales/trends/numbers of opioid market and/or use from the past to 2024 (as extensive as possible)
Hi! I would like to request the following information: 1) Statistics on what are the current opioid prescribed drugs commonly used in the PH 2) Demographics of those who use it and/or who are commonly prescribed with it 3) Current sales/trends/numbers of opioid market and/or use from the past to 2024 (as extensive as possible)
Dear eFOI user,
Mabuhay!
Thank you for utilizing the eFOI portal (www.foi.gov.ph) and exercising your right to information under Executive Order No. 2, s. 2016 on Freedom of Information in the Executive Branch.
We have received your request on Statistics of Prescribed Opioid Use in the Philippines, dated Oct. 5, 2024.
While our primary objective is to provide information whenever possible, we regret to inform you that the requested information is not available at this Office. However, we recommend reaching out to [Philippine Drug Enforcement Agency] at (02) 8927 9702 for further assistance for further assistance. Alternatively, you may resubmit your request to the appropriate agency through the eFOI portal athttps://www.foi.gov.ph/agencies/?status=&category=&q=Philippine+Drug+Enforcement+Agency
For additional support, we encourage you to consult the FAQ section of the eFOI site: https://www.foi.gov.ph/help.
If you are dissatisfied with our response to your FOI request, you have the option to request an internal review. To initiate this process, kindly submit your written appeal for review addressed to Secretary Catalino S. Cuy, CEO VI, at [email protected]. Please provide a detailed explanation of your dissatisfaction with our response within 15 calendar days from the date of receiving this response. We will conduct the review and communicate the outcome within 30 calendar days from the receipt of your review request.
Should you remain unsatisfied with the review outcome, you retain the right to appeal to the Office of the President under Administrative Order No. 22 (s. 2011).
Thank you.
Respectfully,
FOI Officer
Dangerous Drugs Board